Back to search

Microfluidx Ltd

11643516

active
Private Limited Company
england wales
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)

Details

STEVENAGE BIOSCIENCE CATALYST, STEVENAGE, SG1 2FX
Incorporated 25/10/2018

Compliance

Last accounts

31/03/2026

total exemption full

Next accounts due

31/12/2027

On track

Confirmation statement

Last: 17/10/2025

Due 31/10/2026

On track

Industry

21200
Manufacture of pharmaceutical preparations
32500
Manufacture of medical and dental instruments and supplies
71122
Engineering related scientific and technical consulting activities

Officers

Dr. Antoine Jean Espinet

director · Since 25/10/2018

CHIEF EXECUTIVE

FRENCH · ENGLAND · Age 39

Mr Charles Henry Grant Shortland

director · Since 01/04/2020

INVESTMENT DIRECTOR

BRITISH · ENGLAND · Age 34

Also on 4 other boards

Dr Rebecca Thirza Todd

director · Since 09/04/2020

INVESTMENT DIRECTOR

BRITISH · UNITED KINGDOM · Age 53

Also on 3 other boards

Dr Katharine Spink

director · Since 15/03/2022

MANAGING PARTNER

AMERICAN · UNITED STATES · Age 52

Mr Joseph Gentile

director · Since 04/07/2023

COMPANY DIRECTOR

AMERICAN · UNITED STATES · Age 68

Persons with Significant Control

Dr. Antoine Jean Espinet

Significant control

French · England · Age 39

Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, SG1 2FX

Notified 25/10/2018

CompanyRankvs 44+ SIC 21200 peers
80

Financial strength93th percentile among SIC peers · 23/25
Employees93th percentile among SIC peers · 14/15
LiquidityCurrent ratio 6.79× · 20/20
Longevity8 years trading (max 15) · 8/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity8/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2024

Net Worth

£2.6M

Balance sheet strength

Cash

£1.6M

Cash in the bank

Net Current Assets

£1.7M

Working capital

Current Assets

£2.0M

Current Liabilities

£294k

Fixed Assets

£880k

Debtors

£377k

19avg. employees+3

Director Loans(2023)

Company owes directors£1k

Balance Sheet

Intangible assets£429k
Assets less current liabilities£2.6M
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20246.79+£538k
20237.12+£1.5M
20221.99-£529k
202121.49+£362k
2020427.69

Derived from filed accounts. Not audited figures.